These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 11068696)

  • 21. Statistical Properties of Large Sample Tests for Dose Content Uniformity.
    Shen M; Tsong Y; Dong X
    Ther Innov Regul Sci; 2014 Sep; 48(5):613-622. PubMed ID: 30231455
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Generic substitution: issues for problematic drugs.
    Henderson JD; Esham RH
    South Med J; 2001 Jan; 94(1):16-21. PubMed ID: 11213935
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The bootstrap procedure in individual bioequivalence.
    Shao J; Chow SC; Wang B
    Stat Med; 2000 Oct; 19(20):2741-54. PubMed ID: 11033572
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modeling and simulation of biopharmaceutical performance.
    Zhang X; Lionberger RA
    Clin Pharmacol Ther; 2014 May; 95(5):480-2. PubMed ID: 24747237
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantitative assessment of the switchability of generic products.
    Karalis V; Bialer M; Macheras P
    Eur J Pharm Sci; 2013 Nov; 50(3-4):476-83. PubMed ID: 23981332
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessment of powder blend uniformity: Comparison of real-time NIR blend monitoring with stratified sampling in combination with HPLC and at-line NIR Chemical Imaging.
    Bakri B; Weimer M; Hauck G; Reich G
    Eur J Pharm Biopharm; 2015 Nov; 97(Pt A):78-89. PubMed ID: 26455421
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of the performance of two sample thieves for the determination of the content uniformity of a powder blend.
    Garcia TP; Taylor MK; Pande GS
    Pharm Dev Technol; 1998 Feb; 3(1):7-12. PubMed ID: 9532595
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Are generic and brand name drugs different in terms of quality?
    Johns Hopkins Med Lett Health After 50; 2000 Feb; 11(12):8. PubMed ID: 10732507
    [No Abstract]   [Full Text] [Related]  

  • 29. Quality of generic ophthalmic drugs.
    Novack GD
    Ocul Surf; 2013 Jan; 11(1):54-6. PubMed ID: 23321360
    [No Abstract]   [Full Text] [Related]  

  • 30. Sample size determination for assessing equivalence based on proportion ratio under a randomized trial with non-compliance and missing outcomes.
    Lui KJ; Chang KC
    Stat Med; 2008 Jan; 27(1):47-67. PubMed ID: 17708514
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessing bioequivalence and drug interchangeability.
    Chen M; Chow SC
    J Biopharm Stat; 2017; 27(2):272-281. PubMed ID: 27936343
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of generic drugs in Spain.
    García Alonso F
    Methods Find Exp Clin Pharmacol; 1998; 20 Suppl A():3. PubMed ID: 9800719
    [No Abstract]   [Full Text] [Related]  

  • 33. Group sequential design and analysis of clinical equivalence assessment for generic nonsystematic drug products.
    Tsong Y; Zhang JJ; Wang SJ
    J Biopharm Stat; 2004 May; 14(2):359-73. PubMed ID: 15206533
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A modified large sample approach in the assessment of population bioequivalence.
    Quiroz J; Ting N; Wei GC; Burdick RK
    J Biopharm Stat; 2000 Nov; 10(4):527-44. PubMed ID: 11104391
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The development of a blend-sampling technique to assess the uniformity of a powder mixture.
    Garcia TP; Wilkinson SJ; Scott JF
    Drug Dev Ind Pharm; 2001 Apr; 27(4):297-307. PubMed ID: 11411897
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comments on the note for guidance on bioavailability and bioequivalence in the European Union.
    Calvo G
    Methods Find Exp Clin Pharmacol; 1998; 20 Suppl A():11. PubMed ID: 9800721
    [No Abstract]   [Full Text] [Related]  

  • 37. Blend uniformity end-point determination using near-infrared spectroscopy and multivariate calibration.
    Sulub Y; Konigsberger M; Cheney J
    J Pharm Biomed Anal; 2011 Jun; 55(3):429-34. PubMed ID: 21398064
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Statistical simulation study of new proposed uniformity requirement for bioequivalency studies.
    Haynes JD
    J Pharm Sci; 1981 Jun; 70(6):673-5. PubMed ID: 7252814
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alternative confidence intervals for the assessment of bioequivalence in four-period cross-over designs.
    Quiroz J; Ting N; Wei GC; Burdick RK
    Stat Med; 2002 Jul; 21(13):1825-47. PubMed ID: 12111892
    [TBL] [Abstract][Full Text] [Related]  

  • 40. By the way, doctor. I recently switched from Prilosec to its generic form, omeprazole. The generic form doesn't give me as much relief from heartburn as Prilosec does. Aren't generics supposed to be the same as the brand-name drugs?
    Robb-Nicholson C
    Harv Womens Health Watch; 2007 Jan; 14(5):8. PubMed ID: 17304701
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.